CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BLCO

Rifaximin SSD IR

Phase 2
Bausch & Lomb (BLCO)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q4 '27
BLCOPhase 2

Rifaximin SSD IR Phase 2 Est. Readout (RIDE)

Rifaximin SSD IR
Q4 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in Dementia Alzheimer Type

View Full Landscape
Drug Information

Target Indication

Dementia Alzheimer Type

Clinical Trial

NCT06718686

Last updated: 10/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.